Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001891712-26-000002

Director acquired 21,335 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Long Alison S Director 2026-06-01 Grant or award +21,335 127,178 D
Derivatives
Long Alison S Director 2026-06-01 Grant or award · Stock Option (right to buy) +42,671 42,671 D
Loading xslF345X06/form4-06022026_040612.xml…